ArticleEplasty2025
Soft Tissue Reconstruction With Synthetic Electrospun Fiber Matrix Following Musculoskeletal Injury: A Retrospective Case Series.
Article in Eplasty, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Restoration of a stable and functional soft tissue envelope following traumatic injury to the musculoskeletal system is critical. Where primary closure is not feasible, other reconstructive options must be considered to achieve soft tissue coverage of critical structures. Skin substitutes have been utilized to stimulate granulation tissue and support incorporation of autografts. This present study aims to investigate the use of a fully synthetic electrospun fiber matrix (SEFM) (Restrata; Acera Surgical, Inc) in the management of post-traumatic soft tissue defects. The objective of the present retrospective case series was to assess healing outcomes, including time to healing and incidence of complications, following a single application of the SEFM to soft tissue trauma surrounding musculoskeletal injury. Methods: Medical charts of patients with soft tissue injury secondary to musculoskeletal trauma and who were treated with the SEFM in the operating room following bony instrumentation or fasciotomy procedures were retrospectively reviewed following institutional review board approval. Included patients were treated with the SEFM in conjunction with negative pressure wound therapy as a means of preparing open wounds for definitive management via split-thickness skin grafting or secondary intention healing. Results: Eleven patients met the inclusion criteria. Injury etiologies included 8 open fractures in both upper and lower extremities, 2 open foot-crush injuries, and 1 incidence of forearm compartment syndrome. Ten patients achieved complete healing with minimal complications. Conclusions: Preliminary results indicate that the SEFM may be a viable adjunctive treatment for open post-traumatic wound beds to promote granulation tissue for definitive closure.
Indexed as
Identifiers
41822394PMC12975525What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.